What matters most is recognizing progress beyond the scale
A federal judge in Delaware later dismissed the case against Strive Pharmacy
In the SURMOUNT-5 head-to-head trial ( N Engl J Med , May 2025), tirzepatide produced 20.2% average weight loss compared to 13.7% with semaglutide over 72 weeks a 47% greater relative reduction
Ali BA, Allam RM, Hasanin MS, Hassabo AA (2024) Biosynthesis of selenium nanoparticles as a potential therapeutic agent in breast cancer: G2/M arrest and apoptosis induction
As noted by the FSBP CEO Kyle Longton , there is a high discontinuation count for GLP1s, this is one of the primary reasons
But the functional result is the same: a brain losing capacity over time, with current medicine offering few effective interventions to slow or reverse the process